The global medicinal cannabis industry is undergoing a profound transformation, shaped by expanding regulatory frameworks, evolving patient needs, and increasing scientific validation. From the mature markets of Canada and Australia to the rapidly developing regulatory landscapes of Argentina, Thailand, and beyond, countries are redefining how medical cannabis is cultivated, processed, and integrated into healthcare systems. Producers are competing to deliver
Why Third-Party Audits Matter for Medicinal Cannabis: Strengthening Trust, Compliance, and Global Market Access









